These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2984007)

  • 1. The effects of progabide (SL 76002) on locomotor activity and conditioned place preference induced by d-amphetamine.
    Di Scala G; Martin-Iverson MT; Phillips AG; Fibiger HC
    Eur J Pharmacol; 1985 Jan; 107(2):271-4. PubMed ID: 2984007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats.
    Hoffman DC
    Pharmacol Biochem Behav; 1994 Apr; 47(4):907-12. PubMed ID: 8029261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
    Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
    J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity.
    Mithani S; Martin-Iverson MT; Phillips AG; Fibiger HC
    Psychopharmacology (Berl); 1986; 90(2):247-52. PubMed ID: 3097706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil suppresses d-amphetamine-induced place preference conditioning.
    Pucilowski O; Garges PL; Rezvani AH; Hutheson S; Janowsky DS
    Eur J Pharmacol; 1993 Aug; 240(1):89-92. PubMed ID: 8405127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Phenylethylamine-, d-amphetamine-and l-amphetamine-induced place preference conditioning in rats.
    Gilbert D; Cooper SJ
    Eur J Pharmacol; 1983 Nov; 95(3-4):311-4. PubMed ID: 6686144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats.
    Nomikos GG; Spyraki C
    Pharmacol Biochem Behav; 1988 Aug; 30(4):853-8. PubMed ID: 3147460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice.
    Juhila J; Honkanen A; Sallinen J; Haapalinna A; Korpi ER; Scheinin M
    Eur J Pharmacol; 2005 Jul; 517(1-2):74-83. PubMed ID: 15978573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.
    Hiroi N; White NM
    Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for presynaptic dopamine mechanisms underlying amphetamine-conditioned locomotion.
    DiLullo SL; Martin-Iverson MT
    Brain Res; 1992 Apr; 578(1-2):161-7. PubMed ID: 1354997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat.
    Häggkvist J; Lindholm S; Franck J
    Addict Biol; 2009 Jul; 14(3):260-9. PubMed ID: 19298318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced conditioned inhibition following repeated pretreatment with d-amphetamine.
    Harmer CJ; Phillips GD
    Psychopharmacology (Berl); 1999 Feb; 142(2):120-31. PubMed ID: 10102763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of d-govadine on conditioned place preference with d-amphetamine or food reward.
    Nesbit MO; Dias C; Phillips AG
    Behav Brain Res; 2017 Mar; 321():223-231. PubMed ID: 28062254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats.
    Sellings LH; McQuade LE; Clarke PB
    Neuroscience; 2006 Sep; 141(3):1457-68. PubMed ID: 16753267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats.
    Beauchamp MH; Ormerod BK; Jhamandas K; Boegman RJ; Beninger RJ
    Pharmacol Biochem Behav; 2000 Sep; 67(1):29-35. PubMed ID: 11113481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isradipine suppresses amphetamine-induced conditioned place preference and locomotor stimulation in the rat.
    Pucilowski O; Płaźnik A; Overstreet DH
    Neuropsychopharmacology; 1995 May; 12(3):239-44. PubMed ID: 7612157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Wnt signalling dose-dependently impairs the acquisition and expression of amphetamine-induced conditioned place preference.
    Islam F; Xu K; Beninger RJ
    Behav Brain Res; 2017 May; 326():217-225. PubMed ID: 28284949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.